FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308201783> ?p ?o ?g. }

• W4308201783 abstract "Introduction: With the widespread application of Immune checkpoint inhibitors (ICIs), it is important to explore the association between ICIs and cardiac arrhythmias and to characterize the clinical features of ICI-associated cardiac arrhythmias in real-world studies. Objective: The purpose of this study was to characterize the main features of ICI-related cardiac arrhythmias. Methods: From January 2017 to June 2021, data in the Food and Drug Administration Adverse Event Reporting System (FAERS) database were retrieved to conduct the disproportionality analysis. For the ICI-related cardiac arrhythmia detection, signals were detected by reporting odds ratio (ROR) and information component (IC), calculated using two-by-two contingency tables The clinical characteristics of patients reported with ICI-related cardiac arrhythmias were compared between fatal and non-fatal groups, and the time to onset (TTO) following different ICI regimens was further investigated. Multivariate logistic regression was used to evaluate the association between concurrent cardiotoxicities and ICI-associated arrhythmias. Results: We identified a total of 1957 ICI–associated cardiac arrhythmias reports which appeared to influence more men (64.44%) than women (30.76%), with a median age of 68 [interquartile range (IQR) 60–75] years. Cardiac arrhythmias were reported most often in patients with lung, pleura, thymus and heart cancers (38.02% of 1957 patients). Compared with the full database, ICIs were detected with pharmacovigilance of cardiac arrhythmias (ROR025 = 1.16, IC025 = 0.19). Anti-PD-1 and anti-PD-L1 monotherapies were found to be related to higher reporting of arrhythmias, corresponding to ROR025 = 1.03, IC025 = 0.06 and ROR025 = 1.27, IC025 = 0.29, respectively, with the exception of anti-CTLA-4 monotherapies (ROR025 = 0.57, IC025 = −1.21). The spectrum of arrhythmias induced by ICIs differed among therapeutic regimens. There was no significant difference in the onset time between monotherapy and combination regimen. Moreover, reports of ICI-associated arrhythmias were associated with other concurrent cardiotoxicity, including cardiac failure [ROR 2.61 (2.20–3.09)], coronary artery disorders [ROR 2.28 (1.83–2.85)], myocardial disorders [ROR 5.25 (4.44–6.22)], pericardial disorders [ROR 2.76 (2.09–3.64)] and cardiac valve disorders [ROR 3.21 (1.34–7.68)]. Conclusion: ICI monotherapy and combination therapy can lead to cardiac arrhythmias that can result in serious outcomes and tend to occur early. Our findings underscore the importance of early recognition and management of ICI-related cardiac arrhythmias." @default.
• W4308201783 created "2022-11-09" @default.
• W4308201783 creator A5036421260 @default.
• W4308201783 creator A5071933793 @default.
• W4308201783 creator A5077420983 @default.
• W4308201783 date "2022-11-04" @default.
• W4308201783 modified "2023-09-27" @default.
• W4308201783 title "Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system" @default.
• W4308201783 cites W2005366883 @default.
• W4308201783 cites W2015487160 @default.
• W4308201783 cites W2158299492 @default.
• W4308201783 cites W2527905628 @default.
• W4308201783 cites W2529484692 @default.
• W4308201783 cites W2547133566 @default.
• W4308201783 cites W2753432434 @default.
• W4308201783 cites W2769632314 @default.
• W4308201783 cites W2789315292 @default.
• W4308201783 cites W2795067517 @default.
• W4308201783 cites W2806826030 @default.
• W4308201783 cites W2901191795 @default.
• W4308201783 cites W2913035631 @default.
• W4308201783 cites W2952301502 @default.
• W4308201783 cites W2976692781 @default.
• W4308201783 cites W2981588267 @default.
• W4308201783 cites W2984466790 @default.
• W4308201783 cites W3002987143 @default.
• W4308201783 cites W3013813739 @default.
• W4308201783 cites W3025336527 @default.
• W4308201783 cites W3043703771 @default.
• W4308201783 cites W3047018443 @default.
• W4308201783 cites W3108542797 @default.
• W4308201783 cites W3120804503 @default.
• W4308201783 cites W3134400165 @default.
• W4308201783 cites W3139419005 @default.
• W4308201783 cites W3146336022 @default.
• W4308201783 cites W3185021648 @default.
• W4308201783 cites W3212242216 @default.
• W4308201783 cites W3216739371 @default.
• W4308201783 doi "https://doi.org/10.3389/fphar.2022.986357" @default.
• W4308201783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36408225" @default.
• W4308201783 hasPublicationYear "2022" @default.
• W4308201783 type Work @default.
• W4308201783 citedByCount "1" @default.
• W4308201783 countsByYear W43082017832023 @default.
• W4308201783 crossrefType "journal-article" @default.
• W4308201783 hasAuthorship W4308201783A5036421260 @default.
• W4308201783 hasAuthorship W4308201783A5071933793 @default.
• W4308201783 hasAuthorship W4308201783A5077420983 @default.
• W4308201783 hasBestOaLocation W43082017833 @default.
• W4308201783 hasConcept C119060515 @default.
• W4308201783 hasConcept C126322002 @default.
• W4308201783 hasConcept C151956035 @default.
• W4308201783 hasConcept C156957248 @default.
• W4308201783 hasConcept C164705383 @default.
• W4308201783 hasConcept C197934379 @default.
• W4308201783 hasConcept C2777105317 @default.
• W4308201783 hasConcept C2779161974 @default.
• W4308201783 hasConcept C2988455589 @default.
• W4308201783 hasConcept C57658597 @default.
• W4308201783 hasConcept C71924100 @default.
• W4308201783 hasConceptScore W4308201783C119060515 @default.
• W4308201783 hasConceptScore W4308201783C126322002 @default.
• W4308201783 hasConceptScore W4308201783C151956035 @default.
• W4308201783 hasConceptScore W4308201783C156957248 @default.
• W4308201783 hasConceptScore W4308201783C164705383 @default.
• W4308201783 hasConceptScore W4308201783C197934379 @default.
• W4308201783 hasConceptScore W4308201783C2777105317 @default.
• W4308201783 hasConceptScore W4308201783C2779161974 @default.
• W4308201783 hasConceptScore W4308201783C2988455589 @default.
• W4308201783 hasConceptScore W4308201783C57658597 @default.
• W4308201783 hasConceptScore W4308201783C71924100 @default.
• W4308201783 hasLocation W43082017831 @default.
• W4308201783 hasLocation W43082017832 @default.
• W4308201783 hasLocation W43082017833 @default.
• W4308201783 hasLocation W43082017834 @default.
• W4308201783 hasOpenAccess W4308201783 @default.
• W4308201783 hasPrimaryLocation W43082017831 @default.
• W4308201783 hasRelatedWork W2192171349 @default.
• W4308201783 hasRelatedWork W2898266225 @default.
• W4308201783 hasRelatedWork W2982021612 @default.
• W4308201783 hasRelatedWork W3003724372 @default.
• W4308201783 hasRelatedWork W3185021648 @default.
• W4308201783 hasRelatedWork W3215516851 @default.
• W4308201783 hasRelatedWork W4220701557 @default.
• W4308201783 hasRelatedWork W4310255579 @default.
• W4308201783 hasRelatedWork W4323347657 @default.
• W4308201783 hasRelatedWork W4378388318 @default.
• W4308201783 hasVolume "13" @default.
• W4308201783 isParatext "false" @default.
• W4308201783 isRetracted "false" @default.
• W4308201783 workType "article" @default.